Adjacent (not core)
Histone deacetylase inhibitors (HDACi) enhance oncolytic herpes simplex virus in malignant meningioma.
GSE210178Kawamura et al., 2022
Overview
- Modality
- Bulk RNA-seq
- Sample count
- 24
- Patient count
- Not reported
- Institution
- Massachusetts General Hospital
- Corresponding author
- Hiroaki Wakimoto
- Platform
- Illumina HiSeq 2500 (GPL16791)
- Access type
- open
- Tissue preservation
- not_applicable
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- Not reported
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
Peer-reviewed
Publications
- Kawamura Y, et al. Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022. PMID 36271587 · DOI